BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34676651)

  • 1. Zoledronate induced urticarial vasculitis.
    Swarnkar B; Biswal S; Agarwal S; Gupta S
    Dermatol Ther; 2021 Nov; 34(6):e15164. PubMed ID: 34676651
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccine-induced urticarial vasculitis.
    Dash S; Behera B; Sethy M; Mishra J; Garg S
    Dermatol Ther; 2021 Sep; 34(5):e15093. PubMed ID: 34369046
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of omalizumab in the treatment of hypocomplementemic urticarial vasculitis.
    Navarro-Navarro I; Jiménez-Gallo D; Villegas-Romero I; Linares-Barrios M
    Dermatol Ther; 2020 Mar; 33(2):e13237. PubMed ID: 32012397
    [No Abstract]   [Full Text] [Related]  

  • 4. Urticarial Vasculitis Successfully Treated With Omalizumab.
    Ermertcan AT; Aktaş A; Öztürk F; Temiz P
    Cutis; 2021 May; 107(5):E19-E21. PubMed ID: 34288864
    [No Abstract]   [Full Text] [Related]  

  • 5. Urticarial vasculitis from simvastatin: what is the alternative drug?
    Bellini V; Assalve D; Lisi P
    Dermatitis; 2010; 21(4):223-4. PubMed ID: 20646678
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypocomplementemic urticarial vasculitis syndrome: a rare autoimmune entity.
    Balasubramaniam D; Gottwald L; Dominiak N; Rettig N; Bedford-Lyon N; Ahmed M
    Int J Dermatol; 2020 Dec; 59(12):e480-e481. PubMed ID: 32720358
    [No Abstract]   [Full Text] [Related]  

  • 7. Refractory Normocomplementemic Urticarial Vasculitis Showing a Good Response to B-Cell Depletion Therapy.
    Adwan M; Hanbali R; Farah RI
    J Clin Rheumatol; 2021 Dec; 27(8S):S474-S475. PubMed ID: 31743269
    [No Abstract]   [Full Text] [Related]  

  • 8. Cold urticarial vasculitis successfully treated with omalizumab.
    Ayén-Rodríguez A; Llamas-Molina JM; Gálvez-Moreno M; Ruiz-Villaverde R
    Int J Dermatol; 2023 Feb; 62(2):e77-e78. PubMed ID: 35167707
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent optic disc and retinal vasculitis in a patient with drug-induced urticarial vasculitis.
    Batioğlu F; Taner P; Aydintuğ OT; Heper AO; Ozmert E
    Cutan Ocul Toxicol; 2006; 25(4):281-5. PubMed ID: 17162415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urticarial vasculitis.
    Chang S; Carr W
    Allergy Asthma Proc; 2007; 28(1):97-100. PubMed ID: 17390766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus meeting on the definition of physical urticarias and urticarial vasculitis.
    Black AK; Lawlor F; Greaves MW
    Clin Exp Dermatol; 1996 Nov; 21(6):424-6. PubMed ID: 9167337
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypocomplementemic Urticarial Vasculitis Syndrome.
    Umemoto D; Nishioka H
    J Clin Rheumatol; 2023 Apr; 29(3):e15-e16. PubMed ID: 36959201
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypocomplementemic urticarial vasculitis in systemic lupus erythematosus.
    Her MY; Song JY; Kim DY
    J Korean Med Sci; 2009 Feb; 24(1):184-6. PubMed ID: 19270838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urticarial vasculitis secondary to H1N1 vaccination.
    Hughes R; Lacour JP; Baldin B; Reverte M; Ortonne JP; Passeron T
    Acta Derm Venereol; 2010 Nov; 90(6):651-2. PubMed ID: 21057759
    [No Abstract]   [Full Text] [Related]  

  • 15. Urticarial vasculitis following mRNA anti-COVID-19 vaccine.
    Nazzaro G; Maronese CA
    Dermatol Ther; 2022 Mar; 35(3):e15282. PubMed ID: 34931406
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report.
    Horai Y; Ishikawa H; Iwanaga N; Izumi Y; Matsuoka Y; Miura S; Kawakami A
    J Clin Pharm Ther; 2020 Oct; 45(5):1179-1182. PubMed ID: 31990069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
    Highet AS
    Br J Dermatol; 1980 Mar; 102(3):358-60. PubMed ID: 7370185
    [No Abstract]   [Full Text] [Related]  

  • 18. Urticaria and urticarial vasculitis.
    Guha B; Youngberg G; Krishnaswamy G
    Compr Ther; 2003; 29(2-3):146-56. PubMed ID: 14606344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manifestations of drug reactions. Urticaria and cutaneous necrotizing venulitis.
    Gammon WR
    Clin Dermatol; 1986; 4(1):50-7. PubMed ID: 3270403
    [No Abstract]   [Full Text] [Related]  

  • 20. Urticarial vasculitis and urticarial autoinflammatory syndromes.
    Marzano AV; Tavecchio S; Venturini M; Sala R; Calzavara-Pinton P; Gattorno M
    G Ital Dermatol Venereol; 2015 Feb; 150(1):41-50. PubMed ID: 25586657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.